All lobbying filings

W Strategies, LLC

W Strategies, LLC filed a Q3 report for Pharmaceutical Research and Manufacturers of America on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Pharmaceutical Research and Manufacturers of America · A trade group representing pharmaceutical research and biotechnology companies.

As filed: W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA.

All filings by W Strategies, LLC · Everything Pharmaceutical Research and Manufacturers of America has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

PBM reform legislation. 340(b) reform. FY 2027 National Defense Authorization Act. Issues around drug pricing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.